UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen‐deprivation therapy for hormone‐naïve bone‐metastatic prostate cancer

BJU international, 2018-10, Vol.122 (4), p.583-591

2018

Volltextzugriff (PDF)

Clinical presentation and predictors of survival related to extent of bone metastasis in 900 prostate cancer patients

Scandinavian journal of urology, 2016-10, Vol.50 (5), p.352-359

2016

Volltextzugriff (PDF)

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

Scandinavian journal of urology and nephrology, 2011-11, Vol.45 (5), p.346-353

2011

Volltextzugriff (PDF)

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

The lancet oncology, 2009-04, Vol.10 (4), p.370-380

2009

Volltextzugriff (PDF)

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

The Lancet (British edition), 2009, Vol.373 (9660), p.301-308

2009

Volltextzugriff (PDF)

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Scandinavian journal of urology and nephrology, 2008, Vol.42 (3), p.220-229

2008

Volltextzugriff (PDF)

EFFICACY AND TOLERABILITY OF BICALUTAMIDE IN EARLY NON METASTATIC PROSTATE CANCER: LATEST FINDINGS FROM THE SCANDINAVIAN PROSTATIC CANCER GROUP STUDY NO 6 (SPCG-6) OF THE EARLY PROSTATE CANCER PROGRAMME

European urology supplements : official journal of the European Association of Urology, 2006-04, Vol.5 (2), p.251-251

2006

Volltextzugriff (PDF)

Treatment of sex offenders with leuprorelin

Tidsskrift for den Norske Lægeforening, 2006-02, Vol.126 (5), p.633-634

2006

Volltextzugriff (PDF)

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6

The Journal of urology, 2004-11, Vol.172 (5), p.1871-1876

2004

Volltextzugriff (PDF)

Earliest Time to Onset of Action Leading to Successful Intercourse with Vardenafil Determined in an At‐Home Setting: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Journal of sexual medicine, 2004-09, Vol.1 (2), p.168-178

2004

Volltextzugriff (PDF)

Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program

Urology (Ridgewood, N.J.), 2004-05, Vol.63 (5), p.928-933

2004

Volltextzugriff (PDF)

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

Urology (Ridgewood, N.J.), 2003, Vol.61 (1), p.145-151

2003

Volltextzugriff (PDF)

A Randomised Comparison of Bicalutamide (‘Casodex’) 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer: First Report from the Scandinavian Prostatic Cancer Group Study No. 6

European urology, 2002-09, Vol.42 (3), p.204-211

2002

Volltextzugriff (PDF)

A randomised comparison of Bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate Cancer. First report from the scandinavian prostatic Cancer group study no.6

European urology, 2002, Vol.42 (3), p.204-211

2002

Volltextzugriff (PDF)

Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Scandinavian journal of urology and nephrology, 2002, Vol.36 (6), p.405-413

2002

Volltextzugriff (PDF)

1010 Does prophylactic radiotherapy prevent antiandrogen induced gynecomastia? Evaluation of patients in the randomized scandinavian trial SPCG7/SFUO-3

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.262-263

1999

Volltextzugriff (PDF)

Rapid analysis of C19-steroid metabolism by high-performance liquid chromatography and in-line monitoring of radioactivity

Journal of Chromatography, 1998-04, Vol.308, p.289-294

Lundmo, P

1998

Volltextzugriff (PDF)

Combined Androgen Blockade in the Treatment of Advanced Prostate Cancer-an Overview

Scandinavian journal of urology and nephrology, 1997, Vol.31 (3), p.249-254

Iversen, Peter

1997

Volltextzugriff (PDF)

The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin

Cancer research (Chicago, Ill.), 1994-12, Vol.54 (23), p.6167-6175

1994

Volltextzugriff (PDF)

Sexual Function after Transurethral Prostatectomy

Scandinavian journal of urology and nephrology, 1993, Vol.27 (1), p.27-29

1993

Volltextzugriff (PDF)

Androgen regulation of programmed death of normal and malignant prostatic cells

Journal of andrology, 1992-11, Vol.13 (6), p.457-464

1992

Volltextzugriff (PDF)

Digital rectal examination does not increase serum concentrations of prostatic-specific antigen

Clinical chemistry (Baltimore, Md.), 1992-05, Vol.38 (5), p.782

1992

Volltextzugriff (PDF)

Scandinavian Clinical Study of Finasteride in the Treatment of Benign Prostatic Hyperplasia

European urology, 1992, Vol.22 (4), p.271-277

1992

Volltextzugriff (PDF)

Orchidectomy or LHRH-Analogue? Which Do the Patients Prefer and What Treatment Would Norwegian Urologists Prefer if They Had Advanced Cancer of the Prostate?

Scandinavian journal of urology and nephrology, 1991, Vol.25 (3), p.197-199

1991

Volltextzugriff (PDF)

Perinephritic abscess

Tidsskrift for den Norske Lægeforening, 1990-06, Vol.110 (15), p.1952

1990

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(33)

Sprache

Erscheinungsjahr

n.n

Thema

Male
(24)
Science & Technology
(24)
Humans
(22)
Life Sciences & Biomedicine
(22)
Biological And Medical Sciences
(19)
Medical Sciences
(16)
Aged
(14)
Urology & Nephrology
(13)
Middle Aged
(12)
Prostatic Neoplasms - Drug Therapy
(9)
Adult
(8)
Medicin Och Hälsovetenskap
(7)
Prostate Cancer
(7)
Prostatic Neoplasms - Pathology
(7)
Aged, 80 And Over
(6)
Animals
(6)
Nephrology. Urinary Tract Diseases
(6)
Tumors Of The Urinary System
(6)
Urinary Tract. Prostate Gland
(6)
Androgen Antagonists - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen‐deprivation therapy for hormone‐naïve bone‐metastatic prostate cancer

Clinical presentation and predictors of survival related to extent of bone metastasis in 900 prostate cancer patients

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

EFFICACY AND TOLERABILITY OF BICALUTAMIDE IN EARLY NON METASTATIC PROSTATE CANCER: LATEST FINDINGS FROM THE SCANDINAVIAN PROSTATIC CANCER GROUP STUDY NO 6 (SPCG-6) OF THE EARLY PROSTATE CANCER PROGRAMME

Treatment of sex offenders with leuprorelin

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6

Earliest Time to Onset of Action Leading to Successful Intercourse with Vardenafil Determined in an At‐Home Setting: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

A Randomised Comparison of Bicalutamide (‘Casodex’) 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer: First Report from the Scandinavian Prostatic Cancer Group Study No. 6

A randomised comparison of Bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate Cancer. First report from the scandinavian prostatic Cancer group study no.6

Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

1010 Does prophylactic radiotherapy prevent antiandrogen induced gynecomastia? Evaluation of patients in the randomized scandinavian trial SPCG7/SFUO-3

Rapid analysis of C19-steroid metabolism by high-performance liquid chromatography and in-line monitoring of radioactivity

Combined Androgen Blockade in the Treatment of Advanced Prostate Cancer-an Overview

The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin

Sexual Function after Transurethral Prostatectomy

Androgen regulation of programmed death of normal and malignant prostatic cells

Digital rectal examination does not increase serum concentrations of prostatic-specific antigen

Scandinavian Clinical Study of Finasteride in the Treatment of Benign Prostatic Hyperplasia

Orchidectomy or LHRH-Analogue? Which Do the Patients Prefer and What Treatment Would Norwegian Urologists Prefer if They Had Advanced Cancer of the Prostate?

Perinephritic abscess

Suchergebnisse filtern